{"transactions":[{"id":673705,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Restricted Stock Units","published_at":"2026-08-27T20:28:06.000Z","date":"2026-08-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3511,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each outstanding restricted stock unit (a \"Company RSU\"), whether or not vested, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the Merger Consideration, multiplied by (y) the total number of shares subject to such Company RSU immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each outstanding restricted stock unit (a \"Company RSU\"), whether or not vested, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the Merger Consideration, multiplied by (y) the total number of shares subject to such Company RSU immediately prior to the effective time of the Merger."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each outstanding restricted stock unit (a \"Company RSU\"), whether or not vested, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the Merger Consideration, multiplied by (y) the total number of shares subject to such Company RSU immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3511},"source":{"system":"sec-edgar","filing":"0001612842-26-000011","document":"form4-08272026_080801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000161284226000011/form4-08272026_080801.xml","form_type":"4"}},{"id":673704,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Restricted Stock Units","published_at":"2026-08-27T20:28:06.000Z","date":"2026-08-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":180000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each outstanding restricted stock unit (a \"Company RSU\"), whether or not vested, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the Merger Consideration, multiplied by (y) the total number of shares subject to such Company RSU immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each outstanding restricted stock unit (a \"Company RSU\"), whether or not vested, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the Merger Consideration, multiplied by (y) the total number of shares subject to such Company RSU immediately prior to the effective time of the Merger."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each outstanding restricted stock unit (a \"Company RSU\"), whether or not vested, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the Merger Consideration, multiplied by (y) the total number of shares subject to such Company RSU immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001612842-26-000011","document":"form4-08272026_080801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000161284226000011/form4-08272026_080801.xml","form_type":"4"}},{"id":673703,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Restricted Stock Units","published_at":"2026-08-27T20:28:06.000Z","date":"2026-08-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each outstanding restricted stock unit (a \"Company RSU\"), whether or not vested, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the Merger Consideration, multiplied by (y) the total number of shares subject to such Company RSU immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each outstanding restricted stock unit (a \"Company RSU\"), whether or not vested, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the Merger Consideration, multiplied by (y) the total number of shares subject to such Company RSU immediately prior to the effective time of the Merger."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each outstanding restricted stock unit (a \"Company RSU\"), whether or not vested, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the Merger Consideration, multiplied by (y) the total number of shares subject to such Company RSU immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001612842-26-000011","document":"form4-08272026_080801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000161284226000011/form4-08272026_080801.xml","form_type":"4"}},{"id":673702,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-27T20:28:06.000Z","date":"2026-08-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each unexercised and outstanding option to purchase shares of Common Stock (a \"Company Option\"), whether or not vested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the excess (if any) of (a) the Merger Consideration over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to the effective time of the Merger.  At the effective time of the Merger, each Company Option that is then outstanding and unexercised, whether or not vested and which has a per share exercise price that is equal to or greater than the Merger Consideration, shall be cancelled with no consideration payable therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, each unexercised and outstanding option to purchase shares of Common Stock (a \"Company Option\"), whether or not vested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the excess (if any) of (a) the Merger Consideration over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to the effective time of the Merger.  At the effective time of the Merger, each Company Option that is then outstanding and unexercised, whether or not vested and which has a per share exercise price that is equal to or greater than the Merger Consideration, shall be cancelled with no consideration payable therefor."}],"balance_after":0,"derivative":{"exercise_price":17.15,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001612842-26-000011","document":"form4-08272026_080801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000161284226000011/form4-08272026_080801.xml","form_type":"4"}},{"id":673701,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-27T20:28:06.000Z","date":"2026-08-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":270000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each unexercised and outstanding option to purchase shares of Common Stock (a \"Company Option\"), whether or not vested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the excess (if any) of (a) the Merger Consideration over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to the effective time of the Merger.  At the effective time of the Merger, each Company Option that is then outstanding and unexercised, whether or not vested and which has a per share exercise price that is equal to or greater than the Merger Consideration, shall be cancelled with no consideration payable therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, each unexercised and outstanding option to purchase shares of Common Stock (a \"Company Option\"), whether or not vested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the excess (if any) of (a) the Merger Consideration over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to the effective time of the Merger.  At the effective time of the Merger, each Company Option that is then outstanding and unexercised, whether or not vested and which has a per share exercise price that is equal to or greater than the Merger Consideration, shall be cancelled with no consideration payable therefor."}],"balance_after":0,"derivative":{"exercise_price":29.66,"expiration_date":"2036-01-12","underlying":"Common Stock","underlying_shares":270000},"source":{"system":"sec-edgar","filing":"0001612842-26-000011","document":"form4-08272026_080801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000161284226000011/form4-08272026_080801.xml","form_type":"4"}},{"id":673700,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-27T20:28:06.000Z","date":"2026-08-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":920000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each unexercised and outstanding option to purchase shares of Common Stock (a \"Company Option\"), whether or not vested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the excess (if any) of (a) the Merger Consideration over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to the effective time of the Merger.  At the effective time of the Merger, each Company Option that is then outstanding and unexercised, whether or not vested and which has a per share exercise price that is equal to or greater than the Merger Consideration, shall be cancelled with no consideration payable therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, each unexercised and outstanding option to purchase shares of Common Stock (a \"Company Option\"), whether or not vested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the excess (if any) of (a) the Merger Consideration over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to the effective time of the Merger.  At the effective time of the Merger, each Company Option that is then outstanding and unexercised, whether or not vested and which has a per share exercise price that is equal to or greater than the Merger Consideration, shall be cancelled with no consideration payable therefor."}],"balance_after":0,"derivative":{"exercise_price":7.54,"expiration_date":"2035-03-20","underlying":"Common Stock","underlying_shares":920000},"source":{"system":"sec-edgar","filing":"0001612842-26-000011","document":"form4-08272026_080801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000161284226000011/form4-08272026_080801.xml","form_type":"4"}},{"id":673699,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-27T20:28:06.000Z","date":"2026-08-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":44000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each unexercised and outstanding option to purchase shares of Common Stock (a \"Company Option\"), whether or not vested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the excess (if any) of (a) the Merger Consideration over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to the effective time of the Merger.  At the effective time of the Merger, each Company Option that is then outstanding and unexercised, whether or not vested and which has a per share exercise price that is equal to or greater than the Merger Consideration, shall be cancelled with no consideration payable therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, each unexercised and outstanding option to purchase shares of Common Stock (a \"Company Option\"), whether or not vested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the excess (if any) of (a) the Merger Consideration over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to the effective time of the Merger.  At the effective time of the Merger, each Company Option that is then outstanding and unexercised, whether or not vested and which has a per share exercise price that is equal to or greater than the Merger Consideration, shall be cancelled with no consideration payable therefor."}],"balance_after":0,"derivative":{"exercise_price":17.25,"expiration_date":"2034-03-21","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001612842-26-000011","document":"form4-08272026_080801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000161284226000011/form4-08272026_080801.xml","form_type":"4"}},{"id":673698,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-27T20:28:06.000Z","date":"2026-08-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":11999,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each unexercised and outstanding option to purchase shares of Common Stock (a \"Company Option\"), whether or not vested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the excess (if any) of (a) the Merger Consideration over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to the effective time of the Merger.  At the effective time of the Merger, each Company Option that is then outstanding and unexercised, whether or not vested and which has a per share exercise price that is equal to or greater than the Merger Consideration, shall be cancelled with no consideration payable therefor."}],"balance_after":0,"derivative":{"exercise_price":43,"exercise_date":"2026-01-17","expiration_date":"2032-01-17","underlying":"Common Stock","underlying_shares":11999},"source":{"system":"sec-edgar","filing":"0001612842-26-000011","document":"form4-08272026_080801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000161284226000011/form4-08272026_080801.xml","form_type":"4"}},{"id":673697,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-27T20:28:06.000Z","date":"2026-08-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each unexercised and outstanding option to purchase shares of Common Stock (a \"Company Option\"), whether or not vested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the excess (if any) of (a) the Merger Consideration over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to the effective time of the Merger.  At the effective time of the Merger, each Company Option that is then outstanding and unexercised, whether or not vested and which has a per share exercise price that is equal to or greater than the Merger Consideration, shall be cancelled with no consideration payable therefor."}],"balance_after":0,"derivative":{"exercise_price":991.5,"exercise_date":"2025-04-09","expiration_date":"2031-04-09","underlying":"Common Stock","underlying_shares":5400},"source":{"system":"sec-edgar","filing":"0001612842-26-000011","document":"form4-08272026_080801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000161284226000011/form4-08272026_080801.xml","form_type":"4"}},{"id":673696,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-27T20:28:06.000Z","date":"2026-08-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16866,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each unexercised and outstanding option to purchase shares of Common Stock (a \"Company Option\"), whether or not vested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the excess (if any) of (a) the Merger Consideration over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to the effective time of the Merger.  At the effective time of the Merger, each Company Option that is then outstanding and unexercised, whether or not vested and which has a per share exercise price that is equal to or greater than the Merger Consideration, shall be cancelled with no consideration payable therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, each unexercised and outstanding option to purchase shares of Common Stock (a \"Company Option\"), whether or not vested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the excess (if any) of (a) the Merger Consideration over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to the effective time of the Merger.  At the effective time of the Merger, each Company Option that is then outstanding and unexercised, whether or not vested and which has a per share exercise price that is equal to or greater than the Merger Consideration, shall be cancelled with no consideration payable therefor."}],"balance_after":0,"derivative":{"exercise_price":21.5,"expiration_date":"2028-12-19","underlying":"Common Stock","underlying_shares":16866},"source":{"system":"sec-edgar","filing":"0001612842-26-000011","document":"form4-08272026_080801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000161284226000011/form4-08272026_080801.xml","form_type":"4"}},{"id":673695,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2026-08-27T20:28:06.000Z","date":"2026-08-27","kind":"other","planned":false,"acquired":false,"shares":85482,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated July 26, 2026 (the \"Merger Agreement\"), by and among Forte Biosciences, Inc. (\"Company\"), argenx BV (\"Parent\"), and Avena Merger Sub Inc., a wholly owned subsidiary of Parent (\"Purchaser\"), the shares of common stock of Company that were tendered to Purchaser prior to the expiration time of the offer were exchanged for $77.00 per share (\"Merger Consideration\"), net to the seller in cash, without interest, subject to any required withholding tax. After completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into Company (the \"Merger\"), with Company surviving the Merger as a wholly owned subsidiary of Parent."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001612842-26-000011","document":"form4-08272026_080801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000161284226000011/form4-08272026_080801.xml","form_type":"4"}},{"id":714979,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Restricted Stock Units","published_at":"2026-07-06T20:03:25.000Z","date":"2026-07-01","kind":"exercise","planned":false,"acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":2500,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001612842-26-000010","document":"form4-07062026_080721.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000161284226000010/form4-07062026_080721.xml","form_type":"4"}},{"id":714978,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2026-07-06T20:03:25.000Z","date":"2026-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":98,"price":21.32,"value":2089.36,"ownership":{"direct":true},"balance_after":85482,"source":{"system":"sec-edgar","filing":"0001612842-26-000010","document":"form4-07062026_080721.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000161284226000010/form4-07062026_080721.xml","form_type":"4"}},{"id":714977,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2026-07-06T20:03:25.000Z","date":"2026-07-01","kind":"exercise","planned":false,"acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."}],"balance_after":85580,"source":{"system":"sec-edgar","filing":"0001612842-26-000010","document":"form4-07062026_080721.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000161284226000010/form4-07062026_080721.xml","form_type":"4"}},{"id":733869,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-17T20:54:38.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one forty-eighth (1/48th) of the total shares subject to the option shall vest every month following the Vesting Commencement Date such that all shares shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean June 16, 2026."}],"balance_after":500000,"derivative":{"exercise_price":17.15,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001612842-26-000008","document":"form4-06172026_080634.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000161284226000008/form4-06172026_080634.xml","form_type":"4"}},{"id":816096,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Restricted Stock Units","published_at":"2026-04-03T20:01:10.000Z","date":"2026-04-01","kind":"exercise","planned":false,"acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":3750,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001612842-26-000006","document":"form4-04032026_080405.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000161284226000006/form4-04032026_080405.xml","form_type":"4"}},{"id":816095,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2026-04-03T20:01:10.000Z","date":"2026-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":98,"price":24.86,"value":2436.28,"ownership":{"direct":true},"balance_after":84330,"source":{"system":"sec-edgar","filing":"0001612842-26-000006","document":"form4-04032026_080405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000161284226000006/form4-04032026_080405.xml","form_type":"4"}},{"id":816094,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2026-04-03T20:01:10.000Z","date":"2026-04-01","kind":"exercise","planned":false,"acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."}],"balance_after":84428,"source":{"system":"sec-edgar","filing":"0001612842-26-000006","document":"form4-04032026_080405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000161284226000006/form4-04032026_080405.xml","form_type":"4"}},{"id":940005,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Restricted Stock Units","published_at":"2026-01-13T21:10:12.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one fourth (1/4th) of the total RSUs subject to the award shall vest annually on the anniversary of Vesting Commencement Date such that all shares shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean January 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one fourth (1/4th) of the total RSUs subject to the award shall vest annually on the anniversary of Vesting Commencement Date such that all shares shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean January 1, 2026."}],"balance_after":180000,"derivative":{"underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001612842-26-000004","document":"form4-01132026_090104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000161284226000004/form4-01132026_090104.xml","form_type":"4"}},{"id":940004,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-13T21:10:12.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":270000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one forty-eighth (1/48th) of the total shares subject to the option shall vest every month following the Vesting Commencement Date such that all shares shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean January 1, 2026."}],"balance_after":270000,"derivative":{"exercise_price":29.66,"expiration_date":"2036-01-12","underlying":"Common Stock","underlying_shares":270000},"source":{"system":"sec-edgar","filing":"0001612842-26-000004","document":"form4-01132026_090104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000161284226000004/form4-01132026_090104.xml","form_type":"4"}},{"id":955099,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Restricted Stock Units","published_at":"2026-01-02T21:07:50.000Z","date":"2026-01-01","kind":"exercise","planned":false,"acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":5000,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001612842-26-000002","document":"form4-01022026_090147.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000161284226000002/form4-01022026_090147.xml","form_type":"4"}},{"id":955098,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2026-01-02T21:07:50.000Z","date":"2026-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":164,"price":27.27,"value":4472.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 1, 2026, the Reporting Person's RSUs vested. The closing price of the Issuer's Common Stock on December 31, 2025 was the settlement price used to calculate the shares withheld."}],"balance_after":83178,"source":{"system":"sec-edgar","filing":"0001612842-26-000002","document":"form4-01022026_090147.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000161284226000002/form4-01022026_090147.xml","form_type":"4"}},{"id":955097,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2026-01-02T21:07:50.000Z","date":"2026-01-01","kind":"exercise","planned":false,"acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."}],"balance_after":83342,"source":{"system":"sec-edgar","filing":"0001612842-26-000002","document":"form4-01022026_090147.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000161284226000002/form4-01022026_090147.xml","form_type":"4"}},{"id":1027037,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Restricted Stock Units","published_at":"2025-10-02T20:09:17.000Z","date":"2025-10-01","kind":"exercise","planned":false,"acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":6250,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001612842-25-000003","document":"form4-10022025_081009.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000161284225000003/form4-10022025_081009.xml","form_type":"4"}},{"id":1027036,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2025-10-02T20:09:17.000Z","date":"2025-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":98,"price":14.52,"value":1422.96,"ownership":{"direct":true},"balance_after":82092,"source":{"system":"sec-edgar","filing":"0001612842-25-000003","document":"form4-10022025_081009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000161284225000003/form4-10022025_081009.xml","form_type":"4"}},{"id":1027035,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2025-10-02T20:09:17.000Z","date":"2025-10-01","kind":"exercise","planned":false,"acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."}],"balance_after":82190,"source":{"system":"sec-edgar","filing":"0001612842-25-000003","document":"form4-10022025_081009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000161284225000003/form4-10022025_081009.xml","form_type":"4"}},{"id":1092164,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Restricted Stock Units","published_at":"2025-07-03T20:20:51.000Z","date":"2025-07-01","kind":"exercise","planned":false,"acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":7500,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001415889-25-019320","document":"form4-07032025_080747.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588925019320/form4-07032025_080747.xml","form_type":"4"}},{"id":1092163,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2025-07-03T20:20:51.000Z","date":"2025-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":98,"price":12.44,"value":1219.12,"ownership":{"direct":true},"balance_after":80940,"source":{"system":"sec-edgar","filing":"0001415889-25-019320","document":"form4-07032025_080747.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588925019320/form4-07032025_080747.xml","form_type":"4"}},{"id":1092162,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2025-07-03T20:20:51.000Z","date":"2025-07-01","kind":"exercise","planned":false,"acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."}],"balance_after":81038,"source":{"system":"sec-edgar","filing":"0001415889-25-019320","document":"form4-07032025_080747.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588925019320/form4-07032025_080747.xml","form_type":"4"}},{"id":1183157,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Restricted Stock Units","published_at":"2025-04-02T21:01:48.000Z","date":"2025-04-01","kind":"exercise","planned":false,"acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":8750,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001415889-25-009694","document":"form4-04022025_090445.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588925009694/form4-04022025_090445.xml","form_type":"4"}},{"id":1183156,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2025-04-02T21:01:48.000Z","date":"2025-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":18,"price":7.43,"value":133.74,"ownership":{"direct":true},"balance_after":79788,"source":{"system":"sec-edgar","filing":"0001415889-25-009694","document":"form4-04022025_090445.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588925009694/form4-04022025_090445.xml","form_type":"4"}},{"id":1183155,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2025-04-02T21:01:48.000Z","date":"2025-04-01","kind":"exercise","planned":false,"acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."}],"balance_after":79806,"source":{"system":"sec-edgar","filing":"0001415889-25-009694","document":"form4-04022025_090445.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588925009694/form4-04022025_090445.xml","form_type":"4"}},{"id":1194554,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-21T20:39:19.000Z","date":"2025-03-20","kind":"grant","planned":false,"acquired":true,"shares":920000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one thirty-sixth (1/36th) of the total shares subject to the option shall vest every month following the Vesting Commencement Date such that all shares shall be fully vested on the three (3) year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean January 1, 2025."}],"balance_after":920000,"derivative":{"exercise_price":7.54,"expiration_date":"2035-03-20","underlying":"Common Stock","underlying_shares":920000},"source":{"system":"sec-edgar","filing":"0001415889-25-008778","document":"form4-03212025_080315.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588925008778/form4-03212025_080315.xml","form_type":"4"}},{"id":1318529,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Restricted Stock Units","published_at":"2025-01-02T22:09:00.000Z","date":"2025-01-01","kind":"exercise","planned":false,"acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001415889-25-000141","document":"form4-01022025_100156.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588925000141/form4-01022025_100156.xml","form_type":"4"}},{"id":1318528,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2025-01-02T22:09:00.000Z","date":"2025-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":164,"price":22.71,"value":3724.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 1, 2025, the Reporting Person's RSUs vested. The closing price of the Issuer's Common Stock on December 31, 2024 was the settlement price used to calculate the shares withheld."}],"balance_after":78556,"source":{"system":"sec-edgar","filing":"0001415889-25-000141","document":"form4-01022025_100156.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588925000141/form4-01022025_100156.xml","form_type":"4"}},{"id":1318527,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2025-01-02T22:09:00.000Z","date":"2025-01-01","kind":"exercise","planned":false,"acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."}],"balance_after":78720,"source":{"system":"sec-edgar","filing":"0001415889-25-000141","document":"form4-01022025_100156.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588925000141/form4-01022025_100156.xml","form_type":"4"}},{"id":1394251,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Restricted Stock Units","published_at":"2024-10-02T22:19:04.000Z","date":"2024-10-01","kind":"exercise","planned":false,"acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reported number of securities has been adjusted to reflect the Issuer's 1-for-25 reverse stock split effected on August 28, 2024."}],"balance_after":11250,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001415889-24-024494","document":"form4-10022024_101001.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588924024494/form4-10022024_101001.xml","form_type":"4"}},{"id":1394250,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-10-02T22:19:04.000Z","date":"2024-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":98,"price":5.16,"value":505.68,"ownership":{"direct":true},"balance_after":77470,"source":{"system":"sec-edgar","filing":"0001415889-24-024494","document":"form4-10022024_101001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588924024494/form4-10022024_101001.xml","form_type":"4"}},{"id":1394249,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-10-02T22:19:04.000Z","date":"2024-10-01","kind":"exercise","planned":false,"acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reported number of securities has been adjusted to reflect the Issuer's 1-for-25 reverse stock split effected on August 28, 2024."}],"balance_after":77568,"source":{"system":"sec-edgar","filing":"0001415889-24-024494","document":"form4-10022024_101001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588924024494/form4-10022024_101001.xml","form_type":"4"}},{"id":1459681,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Restricted Stock Units","published_at":"2024-07-03T16:17:14.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":false,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":312500,"derivative":{"underlying":"Common Stock","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001415889-24-019122","document":"form4-07032024_040711.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588924019122/form4-07032024_040711.xml","form_type":"4"}},{"id":1459680,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-07-03T16:17:14.000Z","date":"2024-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":2453,"price":0.546,"value":1339.338,"ownership":{"direct":true},"balance_after":1907971,"source":{"system":"sec-edgar","filing":"0001415889-24-019122","document":"form4-07032024_040711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588924019122/form4-07032024_040711.xml","form_type":"4"}},{"id":1459679,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-07-03T16:17:14.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."}],"balance_after":1910424,"source":{"system":"sec-edgar","filing":"0001415889-24-019122","document":"form4-07032024_040711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588924019122/form4-07032024_040711.xml","form_type":"4"}},{"id":1553265,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Restricted Stock Units","published_at":"2024-04-02T22:31:00.000Z","date":"2024-04-01","kind":"exercise","planned":false,"acquired":false,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":343750,"derivative":{"underlying":"Common Stock","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001415889-24-009857","document":"form4-04022024_100445.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588924009857/form4-04022024_100445.xml","form_type":"4"}},{"id":1553264,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-04-02T22:31:00.000Z","date":"2024-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":2453,"price":0.7075,"value":1735.4975,"ownership":{"direct":true},"balance_after":1879174,"source":{"system":"sec-edgar","filing":"0001415889-24-009857","document":"form4-04022024_100445.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588924009857/form4-04022024_100445.xml","form_type":"4"}},{"id":1553263,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-04-02T22:31:00.000Z","date":"2024-04-01","kind":"exercise","planned":false,"acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."}],"balance_after":1881627,"source":{"system":"sec-edgar","filing":"0001415889-24-009857","document":"form4-04022024_100445.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588924009857/form4-04022024_100445.xml","form_type":"4"}},{"id":1561806,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-25T20:07:38.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":1100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the amended and restated 2021 Equity Incentive Plan) through each applicable vesting date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date and one forty-eighth (1/48th) of the total shares subject to the option shall vest every month thereafter such that all shares shall be fully vested on the four year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean March 21, 2024."}],"balance_after":1100000,"derivative":{"exercise_price":0.69,"expiration_date":"2034-03-21","underlying":"Common Stock","underlying_shares":1100000},"source":{"system":"sec-edgar","filing":"0001415889-24-009030","document":"form4-03252024_080331.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588924009030/form4-03252024_080331.xml","form_type":"4"}},{"id":1691883,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2024-01-03T21:01:00.000Z","date":"2024-01-01","kind":"exercise","planned":false,"acquired":false,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":375000,"derivative":{"underlying":"Common Stock","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001209191-24-000316","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919124000316/doc4.xml","form_type":"4"}},{"id":1691882,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-01-03T21:01:00.000Z","date":"2024-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4109,"price":0.8217,"value":3376.3653,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 1, 2024, the Reporting Person's RSUs vested. The closing price of Forte Biosciences, Inc.'s Common Stock on December 29, 2023 was the settlement price used to calculate the shares withheld."}],"balance_after":1850377,"source":{"system":"sec-edgar","filing":"0001209191-24-000316","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919124000316/doc4.xml","form_type":"4"}},{"id":1691881,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-01-03T21:01:00.000Z","date":"2024-01-01","kind":"exercise","planned":false,"acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."}],"balance_after":1854486,"source":{"system":"sec-edgar","filing":"0001209191-24-000316","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919124000316/doc4.xml","form_type":"4"}},{"id":1703266,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-12-20T15:56:32.000Z","date":"2023-12-18","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.7525,"value":7525.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 10,000 shares purchased in the price range of $0.70 to $0.77 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":1823236,"source":{"system":"sec-edgar","filing":"0001209191-23-059297","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123059297/doc4.xml","form_type":"4"}},{"id":1709082,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-12-15T23:29:33.000Z","date":"2023-12-14","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.72,"value":7200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 10,000 shares purchased in the price range of $0.7199 to $0.72 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":1813236,"source":{"system":"sec-edgar","filing":"0001209191-23-058867","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123058867/doc4.xml","form_type":"4"}},{"id":1709081,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-12-15T23:29:33.000Z","date":"2023-12-13","kind":"purchase","planned":false,"acquired":true,"shares":10520,"price":0.6988,"value":7351.376,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 10,520 shares purchased in the price range of $0.679 to $0.70 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":1803236,"source":{"system":"sec-edgar","filing":"0001209191-23-058867","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123058867/doc4.xml","form_type":"4"}},{"id":1714055,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-12-13T00:30:27.000Z","date":"2023-12-12","kind":"purchase","planned":false,"acquired":true,"shares":4776,"price":0.6466,"value":3088.1616,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 4,776 shares purchased in the price range of $0.639 to $0.65 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":1792716,"source":{"system":"sec-edgar","filing":"0001209191-23-058404","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123058404/doc4.xml","form_type":"4"}},{"id":1714054,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-12-13T00:30:27.000Z","date":"2023-12-11","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":0.6475,"value":16187.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 25,000 shares purchased in the price range of $0.6199 to $0.65 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":1787940,"source":{"system":"sec-edgar","filing":"0001209191-23-058404","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123058404/doc4.xml","form_type":"4"}},{"id":1717728,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-12-09T00:20:21.000Z","date":"2023-12-08","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":0.62,"value":9300.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 15,000 shares purchased in the price range of $0.6085 to $0.62 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":1762940,"source":{"system":"sec-edgar","filing":"0001209191-23-057989","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123057989/doc4.xml","form_type":"4"}},{"id":1717727,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-12-09T00:20:21.000Z","date":"2023-12-07","kind":"purchase","planned":false,"acquired":true,"shares":36203,"price":0.5847,"value":21167.8941,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 36,203 shares purchased in the price range of $0.54 to $0.60 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":1747940,"source":{"system":"sec-edgar","filing":"0001209191-23-057989","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123057989/doc4.xml","form_type":"4"}},{"id":1731034,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-11-22T22:51:29.000Z","date":"2023-11-22","kind":"purchase","planned":false,"acquired":true,"shares":400,"price":0.43,"value":172.0,"ownership":{"direct":true},"balance_after":1711737,"source":{"system":"sec-edgar","filing":"0001209191-23-056522","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123056522/doc4.xml","form_type":"4"}},{"id":1731033,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-11-22T22:51:29.000Z","date":"2023-11-20","kind":"purchase","planned":false,"acquired":true,"shares":100,"price":0.4251,"value":42.51,"ownership":{"direct":true},"balance_after":1711337,"source":{"system":"sec-edgar","filing":"0001209191-23-056522","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123056522/doc4.xml","form_type":"4"}},{"id":1731032,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-11-22T22:51:29.000Z","date":"2023-11-20","kind":"purchase","planned":false,"acquired":true,"shares":1566,"price":0.43,"value":673.38,"ownership":{"direct":true},"balance_after":1711237,"source":{"system":"sec-edgar","filing":"0001209191-23-056522","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123056522/doc4.xml","form_type":"4"}},{"id":1731031,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-11-22T22:51:29.000Z","date":"2023-11-20","kind":"purchase","planned":false,"acquired":true,"shares":5300,"price":0.44,"value":2332.0,"ownership":{"direct":true},"balance_after":1709671,"source":{"system":"sec-edgar","filing":"0001209191-23-056522","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123056522/doc4.xml","form_type":"4"}},{"id":1767177,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-10-03T20:26:23.000Z","date":"2023-10-01","kind":"exercise","planned":false,"acquired":false,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":406250,"derivative":{"underlying":"Common Stock","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001209191-23-051476","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123051476/doc4.xml","form_type":"4"}},{"id":1767176,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-10-03T20:26:23.000Z","date":"2023-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":2453,"price":0.662,"value":1623.886,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On October 1, 2023, the Reporting Person's RSUs vested. The closing price of Forte Biosciences, Inc.'s Common Stock on September 29, 2023 was the settlement price used to calculate the shares withheld."}],"balance_after":1704371,"source":{"system":"sec-edgar","filing":"0001209191-23-051476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123051476/doc4.xml","form_type":"4"}},{"id":1767175,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-10-03T20:26:23.000Z","date":"2023-10-01","kind":"exercise","planned":false,"acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."}],"balance_after":1706824,"source":{"system":"sec-edgar","filing":"0001209191-23-051476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123051476/doc4.xml","form_type":"4"}},{"id":1817766,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-08-02T21:56:08.000Z","date":"2023-07-31","kind":"grant","planned":false,"acquired":true,"shares":247524,"price":1.01,"value":249999.24,"ownership":{"direct":true},"balance_after":1675574,"source":{"system":"sec-edgar","filing":"0001209191-23-044280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123044280/doc4.xml","form_type":"4"}},{"id":1835850,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-07-05T20:04:52.000Z","date":"2023-07-01","kind":"exercise","planned":false,"acquired":false,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":437500,"derivative":{"underlying":"Common Stock","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001209191-23-040961","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123040961/doc4.xml","form_type":"4"}},{"id":1835849,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-07-05T20:04:52.000Z","date":"2023-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":2453,"price":1.04,"value":2551.12,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 1, 2023, the Reporting Person's RSUs vested. The closing price of Forte Biosciences, Inc.'s Common Stock on June 30, 2023 was the settlement price used to calculate the shares withheld."}],"balance_after":1428050,"source":{"system":"sec-edgar","filing":"0001209191-23-040961","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123040961/doc4.xml","form_type":"4"}},{"id":1835848,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-07-05T20:04:52.000Z","date":"2023-07-01","kind":"exercise","planned":false,"acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."}],"balance_after":1430503,"source":{"system":"sec-edgar","filing":"0001209191-23-040961","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123040961/doc4.xml","form_type":"4"}},{"id":1927740,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-04-05T00:19:41.000Z","date":"2023-04-01","kind":"exercise","planned":false,"acquired":false,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":468750,"derivative":{"underlying":"Common Stock","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001209191-23-023083","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123023083/doc4.xml","form_type":"4"}},{"id":1927739,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-04-05T00:19:41.000Z","date":"2023-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":11046,"price":1.01,"value":11156.46,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On April 1, 2023, the Reporting Person's RSUs vested. The closing price of Forte Biosciences, Inc.'s Common Stock on March 31, 2023 was the settlement price used to calculate the shares withheld."}],"balance_after":1399253,"source":{"system":"sec-edgar","filing":"0001209191-23-023083","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123023083/doc4.xml","form_type":"4"}},{"id":1927738,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-04-05T00:19:41.000Z","date":"2023-04-01","kind":"exercise","planned":false,"acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."}],"balance_after":1410299,"source":{"system":"sec-edgar","filing":"0001209191-23-023083","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123023083/doc4.xml","form_type":"4"}},{"id":1940092,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-03-23T20:17:16.000Z","date":"2023-03-23","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":500000,"derivative":{"underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001209191-23-020744","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123020744/doc4.xml","form_type":"4"}},{"id":2081441,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-12-19T21:21:25.000Z","date":"2022-12-16","kind":"purchase","acquired":true,"shares":44024,"price":1.0676,"value":47000.0224,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 44,024 shares purchased in the price range of $1.03 to $1.09 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":1379049,"source":{"system":"sec-edgar","filing":"0001209191-22-061903","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919122061903/doc4.xml","form_type":"4"}},{"id":2081440,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-12-19T21:21:25.000Z","date":"2022-12-15","kind":"purchase","acquired":true,"shares":55976,"price":1.0303,"value":57672.0728,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 55,976 shares purchased in the price range of $1.00 to $1.08 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":1335025,"source":{"system":"sec-edgar","filing":"0001209191-22-061903","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919122061903/doc4.xml","form_type":"4"}},{"id":2270185,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-16T21:05:47.000Z","date":"2022-05-12","kind":"disposition_to_issuer","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"40,000 of the shares subject to this option were canceled by mutual agreement of the Reporting Person and the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2017 Equity Incentive Plan) through each applicable vesting date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date and one forty-eighth (1/48th) of the total shares subject to the option shall vest every month thereafter such that all shares shall be fully vested on the four year anniversary of the Vesting Commencement Date.  \"Vesting Commencement Date\" shall mean April 9, 2021."}],"balance_after":135000,"derivative":{"exercise_price":39.66,"expiration_date":"2031-04-09","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-22-029214","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919122029214/doc4.xml","form_type":"4"}},{"id":2433634,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-19T01:26:10.000Z","date":"2022-01-17","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person's Continuous Service (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date and one forty-eighth (1/48th) of the total shares subject to the option shall vest every month thereafter such that all shares shall be fully vested on the four year anniversary of the Vesting Commencement Date.  \"Vesting Commencement Date\" shall mean January 17, 2022."}],"balance_after":300000,"derivative":{"exercise_price":1.72,"expiration_date":"2032-01-17","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000899243-22-002261","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000089924322002261/doc4.xml","form_type":"4"}},{"id":2575835,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-09-08T21:02:40.000Z","date":"2021-09-07","kind":"sale","acquired":false,"shares":1000000,"price":4.3471,"value":4347100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 1,000,000 shares sold in the price range of $4.1403 to $4.64 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1279049,"source":{"system":"sec-edgar","filing":"0000899243-21-035344","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000089924321035344/doc4.xml","form_type":"4"}},{"id":2750333,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2021-04-13T22:03:19.000Z","date":"2021-04-09","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person's Continuous Service (as defined in the 2017 Equity Incentive Plan) through each applicable vesting date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date and one forty-eighth (1/48th) of the total shares subject to the option shall vest every month thereafter such that all shares shall be fully vested on the four year anniversary of the Vesting Commencement Date.  \"Vesting Commencement Date\" shall mean April 9, 2021."}],"balance_after":175000,"derivative":{"exercise_price":39.66,"expiration_date":"2031-04-09","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0000899243-21-015641","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000089924321015641/doc4.xml","form_type":"4"}},{"id":3097487,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-06-30T00:13:05.000Z","date":"2020-06-25","kind":"purchase","acquired":true,"shares":7000,"price":14.4794,"value":101355.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 7,000 shares purchased in the price range of $14.1620 to $14.9899 by the Reporting Person. The Reporting Person undertakes to provide upon request\nby the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":2279049,"source":{"system":"sec-edgar","filing":"0001209191-20-039272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919120039272/doc4.xml","form_type":"4"}},{"id":4382358,"issuer":{"id":146052,"kind":"organization","name":"Pfenex Inc.","symbol":"PFNX"},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-03-16T18:18:28.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% shall vest on the one year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the Option shall vest every month thereafter such that all shares shall be fully vested on the four year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean March 1, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This amendment is being filed to correct the expiration date of the Option."}],"balance_after":85000,"derivative":{"exercise_price":7.47,"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0000899243-17-007812","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478121/000089924317007812/doc4a.xml","form_type":"4/A","original_submission_date":"2017-03-02"}},{"id":4409421,"issuer":{"id":146052,"kind":"organization","name":"Pfenex Inc.","symbol":"PFNX"},"owners":[{"id":19059,"kind":"person","name":"Wagner Paul A.","position":1,"cik":"0001612842","reported_name":"Wagner Paul A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-03-02T17:08:47.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% shall vest on the one year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the Option shall vest every month thereafter such that all shares shall be fully vested on the four year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean March 1, 2017."}],"balance_after":85000,"derivative":{"exercise_price":7.47,"expiration_date":"2017-03-01","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0000899243-17-006102","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478121/000089924317006102/doc4.xml","form_type":"4"}}]}